1. Assessing Unique Risk Factors for COVID-19 Complications Among Cancer Patients: A Multi-ethnic Cohort Study.
- Author
-
Borno, Hala T, Borno, Hala T, Kim, Mi-Ok, Tolstykh, Irina, Lin, Amy, Hong, Julian C, Yousefi, Sasha, Zhang, Sylvia, McKay, Rana R, Harismendy, Olivier, Razavi, Pedram, Cinar, Pelin, Rugo, Hope, Koshkin, Vadim S, Rabow, Maya, Wang, Christine, Bailey, Adina, Small, Eric J, Borno, Hala T, Borno, Hala T, Kim, Mi-Ok, Tolstykh, Irina, Lin, Amy, Hong, Julian C, Yousefi, Sasha, Zhang, Sylvia, McKay, Rana R, Harismendy, Olivier, Razavi, Pedram, Cinar, Pelin, Rugo, Hope, Koshkin, Vadim S, Rabow, Maya, Wang, Christine, Bailey, Adina, and Small, Eric J
- Abstract
A myriad of organ-specific complications have been observed with COVID-19. While racial/ethnic minorities have been disproportionately burdened by this disease, our understanding of the unique risk factors for complications among a diverse population of cancer patients remains limited. This is a multi-institutional, multi-ethnic cohort study evaluating COVID-19 complications among cancer patients. Patients with an invasive cancer diagnosis and confirmed SARS-CoV-2 infection were identified from March to November 2020. Demographic and clinical data were obtained and a multivariate logistic regression was employed to evaluate the impact of demographic and clinical factors on COVID-19 complications. The study endpoints were evaluated independently and included any complication, sepsis, pulmonary complications and cardiac complications. A total of 303 patients were evaluated, of whom 48% were male, 79% had solid tumors, and 42% were Hispanic/Latinx (Hispanic). Malignant hematologic cancers were associated with a higher risk of sepsis (OR 3.93 (95% CI 1.58-9.81)). Male patients had a higher risk of sepsis (OR 4.42 (95% CI 1.63-11.96)) and cardiac complications (OR 2.02 (95% CI 1.05-3.89)). Hispanic patients had a higher odds of any complication (OR 2.31 (95% CI 1.18-4.51)) and other race was associated with a higher odds of cardiac complications (OR 2.41 (95% CI 1.01-5.73)). Clinically, fever, cough, and ≥2 co-morbidities were independently significantly associated with any complication. This analysis evaluated covariates that can significantly predict a myriad of complications among a multi-ethnic cohort of cancer patients. The conclusions drawn from this analysis elucidate a mechanistic understanding of differential illness severity from COVID-19.
- Published
- 2023